checkAd

     137  0 Kommentare Cadence and NVIDIA Unveil Groundbreaking Generative AI and Accelerated Compute-Driven Innovations

    Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced an expansion of its multi-year collaboration with NVIDIA across EDA, system design and analysis, digital biology and AI with the unveiling of two transformative solutions to reinvent design using accelerated computing and generative AI.

    First, the new Cadence Reality Digital Twin Platform is the industry’s pioneering comprehensive digital twin solution to facilitate speed-of-light acceleration of the design, simulation and optimization of data centers across multiple industries. The platform virtualizes the entire data center and uses AI, high-performance computing (HPC) and physics-based simulation to significantly improve data center energy efficiency by up to 30%.

    Anzeige 
    Handeln Sie Ihre Einschätzung zu Cadence Design Systems!
    Long
    265,70€
    Basispreis
    1,61
    Ask
    × 14,33
    Hebel
    Short
    300,71€
    Basispreis
    1,92
    Ask
    × 12,59
    Hebel
    Präsentiert von

    Den Basisprospekt sowie die Endgültigen Bedingungen und die Basisinformationsblätter erhalten Sie bei Klick auf das Disclaimer Dokument. Beachten Sie auch die weiteren Hinweise zu dieser Werbung.

    The Cadence Reality platform’s integration with NVIDIA Omniverse brings OpenUSD data interoperability and physically based rendering to the digital twin solution—helping accelerate data center design and simulation workflows by 30X.

    Second, the companies are collaborating on generative AI to dramatically accelerate approaches to drug discovery. Cadence’s cloud-native molecular design platform Orion will now be supercharged with NVIDIA’s generative AI tool, NVIDIA BioNeMo, and NVIDIA microservices for drug discovery to broaden therapeutic design capabilities and shorten time to trusted results. The collaboration brings together decades of expertise in scientific software and accelerated computing from the two companies to deliver transformative approaches to drug discovery. Accelerated by on-demand GPU access at an unprecedented scale, pharmaceutical companies can quickly and reliably generate and assess design hypotheses across a range of therapeutic modalities, including biologics, peptides and small molecules.

    “The broadening collaboration between NVIDIA and Cadence is having a transformative impact on everything from data center design to drug discovery,” said Dr. Anirudh Devgan, president and CEO, Cadence. “As AI rapidly becomes a keystone technology driving data center and data center workload expansion, the Cadence Reality Digital Twin Platform integration with NVIDIA Omniverse will optimize every aspect of data center design and operations, use energy more efficiently, and pave the way for a more efficient, resilient, and environmentally friendly future. Our groundbreaking efforts with NVIDIA to integrate BioNeMo with our industry-leading Orion molecular design tools hold great promise for unlocking new ideas and transforming the future of therapeutics and drug discovery. Together, NVIDIA and Cadence are leading the AI revolution.”

    Seite 1 von 3



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Cadence and NVIDIA Unveil Groundbreaking Generative AI and Accelerated Compute-Driven Innovations Cadence Design Systems, Inc. (Nasdaq: CDNS) today announced an expansion of its multi-year collaboration with NVIDIA across EDA, system design and analysis, digital biology and AI with the unveiling of two transformative solutions to reinvent design …

    Schreibe Deinen Kommentar

    Disclaimer